Chickenpox Vaccine: all 75 studies that test it
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese ChildrenNot yet recruitingNCT07473427Phase 3
- SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 YearsRecruitingNCT07415252Phase 3
- An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella VaccineEnrolling by invitationNCT06484686Phase 4
- An Immunity Persistence Study of Live Attenuated Varicella VaccineEnrolling by invitationNCT05095701Phase 4
- Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation RecipientsRecruitingNCT00492739Phase 2/3
- Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and InfantsCompletedNCT04398706Phase 2Results posted
- Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)CompletedNCT03843632Phase 3Results posted
- Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and ToddlersCompletedNCT03691610Phase 3Results posted
- Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™CompletedNCT02958345Phase 4Results posted
- Immune Response to Shingles VaccinationCompletedNCT02624375Phase 4Results posted
- Effects of Chronic Viral Infection on Immune Response to Zoster VaccinationTerminatedNCT02590068Not applicableResults posted
- Study to Evaluate Immunogenicity, Safety, and Tolerability of ZOSTAVAX™ Vaccine (Zoster Vaccine Live, V211) Administered Concomitantly Versus Nonconcomitantly With Quadrivalent Influenza Virus Vaccine (Inactivated) in Participants ≥50 Years of Age (V211-062)CompletedNCT02519855Phase 3Results posted
- ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ TumorsTerminatedNCT02444936Phase 4Results posted
- T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020CompletedNCT01911065Phase 4Results posted
- ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)CompletedNCT01556451Phase 4Results posted
- Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)CompletedNCT01527370Phase 3Results posted
- Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)CompletedNCT01505647Phase 3Results posted
- Immunogenicity and Safety Study of ZOSTAVAX Administered by Intramuscular or Subcutaneous Route to Participants Aged From 50 Years Old (V211-045)CompletedNCT01391546Phase 3Results posted
- A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2)CompletedNCT01385566Phase 1Results posted
- Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of AgeCompletedNCT01346293Phase 3Results posted
- Systems Biology of Zoster Vaccine (ZOSTAVAX®) in Young and ElderlyCompletedNCT01331161Not applicableResults posted
- Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)CompletedNCT01245751Phase 3Results posted
- Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral TherapyCompletedNCT00851786Phase 2Results posted
- Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed)CompletedNCT00822237Phase 3Results posted
- Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy InfantsCompletedNCT00806195Phase 3Results posted
- Zostavax® at Minimum Release Specification Approaching Expiry (V211-044)CompletedNCT00681031Phase 4Results posted
- Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate VaccineCompletedNCT00624819Phase 3Results posted
- Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043)CompletedNCT00561080Phase 3Results posted
- ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020)CompletedNCT00550745Phase 4Results posted
- ZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids (V211-017) (COMPLETED)CompletedNCT00546819Phase 2Results posted
- Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)CompletedNCT00534248Phase 3Results posted
- A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)CompletedNCT00322231Phase 3Results posted
- Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate VaccineCompletedNCT00289783Phase 3Results posted
- A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)CompletedNCT00231816Phase 3Results posted
- Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and ChickenpoxCompletedNCT00226499Phase 3Results posted
- Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in ChildrenCompletedNCT00197015Phase 3Results posted
- Study on Booster Immunization With Varicella Vaccine at Different IntervalsCompletedNCT06994052Phase 4
- Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and ToddlersTerminatedNCT06397768Phase 3
- Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the PhilippinesCompletedNCT06314724Phase 3
- A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella VaccineActive, not recruitingNCT05669625Phase 3
- Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Anhui ProvinceStatus unknownNCT05470855Phase 4
- Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster VirusStatus unknownNCT05460429Phase 4
- An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster ImmunizationCompletedNCT05150392Phase 3
- The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using AbataceptCompletedNCT03604406Phase 2
- A Study of MG1111 in Healthy ChildrenCompletedNCT03375502Phase 2/3
- Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A VaccineStatus unknownNCT03330171Phase 4
- Optimal Timing of Zoster Vaccine After Hematopoietic Stem Cell TransplantationCompletedNCT03192319Not applicable
- A Blind, Randomized and Controlled Study of Live Attenuated Varicella VaccinesCompletedNCT02981836Phase 3
- A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and ChildrenCompletedNCT02965404Phase 1
- Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and OlderTerminatedNCT02960399Not applicable
- Optimal Timing of Zoster Vaccine After Zoster IllnessCompletedNCT02704572Not applicable
- Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus VaccineStatus unknownNCT02514018Phase 4
- Safety and Immunogenicity of a Zoster Vaccine in SLECompletedNCT02477150Phase 4
- Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic TherapyTerminatedNCT02408159Phase 4
- Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against ChickenpoxStatus unknownNCT02383797Phase 4
- VZV Vaccine for Hematopoietic Stem Cell TransplantationCompletedNCT02329457Phase 2/3
- Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year OldsCompletedNCT02114333Phase 1
- Persistence of Varicella Immunity in Hospital Employees Receiving Varicella VaccineWithdrawnNCT02026089Phase 4
- Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in ChildrenStatus unknownNCT01982409Phase 4
- iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and NeuroblastomaActive, not recruitingNCT01953900Phase 1
- The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose VaccinationStatus unknownNCT01830283Phase 4
- Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella VaccineCompletedNCT01817270Phase 4
- Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE VaccineCompletedNCT01815073Phase 4
- Herpes Zoster Vaccine for Bone Marrow Transplant DonorsCompletedNCT01573182Phase 2
- Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care ResidentsCompletedNCT01262300Phase 1
- Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-StudyWithdrawnNCT01213810Phase 1/2
- Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney TransplantationCompletedNCT00940940Phase 4
- Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector DeliveryStatus unknownNCT00926419Phase 2/3
- Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)CompletedNCT00496327Phase 3
- ZOSTAVAX(R) Local Registration Trial (V211-019)CompletedNCT00444860Phase 3
- Safety Study of a Refrigerator-stable Formulation of VARIVAX®CompletedNCT00432731Phase 4
- Immune Responses to Two Dose Varivax +/- MMR-IITerminatedNCT00258726Phase 1/2
- The Safety of Oka Varicella in Children Prior to Solid Organ TransplantationCompletedNCT00213304Phase 3
- Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)CompletedNCT00109122Phase 2
- Evaluation of the Safety of Varivax® in Pediatric Renal Transplant RecipientsTerminatedNCT00005009Phase 1